Evidence mapPaperPMID 40014597Full record

ArticlePloS one2025

Risk factors for osteoporosis in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis.

Wenhao Su, Hairong Jia, Luo Yang, Jiaqi Zhang, Zhaoyang Wei, Pepertual Tsikwa, Yanru Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenhao SuSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Hairong JiaSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Luo YangSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Jiaqi ZhangSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhaoyang WeiSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Pepertual TsikwaSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yanru WangSchool of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0009-0008-8306-9017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoporosis is a prevalent chronic result of diabetes. Osteoporosis susceptibility is raised by unstable blood glucose levels, oxidative stress, hormonal abnormalities, and other factors. Currently, there is no systematic review addressing the risk factors of osteoporosis in diabetes. This study intends to systematically assess the current risk factors related to diabetic osteoporosis (DOP) and provide suggestions for the improvement of therapy approaches. METHODS AND ANALYSIS: We will search five English literature databases (PubMed, Embase, Web of Science, CINAHL, and Cochrane Library) and three Chinese databases (CNKI, WanFang, and SinoMed) from the starting point until December 31, 2024. We will perform a systematic examination and meta-analysis of cohort and case-control studies to identify all population-based risk factors for diabetic osteoporosis. Two researchers will independently assess the publication, extract data, and evaluate the quality and potential biases present in the study. We will utilize RevMan V.5.4 software and STATA 16.0 for data analysis. The included studies will be assessed using the Newcastle Ottawa Quality Assessment Instrument (NOS). If the heterogeneity of the included studies is higher than 50%, we will perform subgroup and sensitivity analysis to identify probable sources of heterogeneity. The assessment of publication bias will be conducted using funnel plot. Furthermore, we will employ the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to assess the quality of evidence for each exposure and outcome. DISCUSSION: This protocol aims to investigate the risk variables associated with DOP. We will summarize the current knowledge about factors influencing osteoporosis in diabetes. We strive to assist physicians with more extensive references for decision-making and facilitate the implementation of effective prevention strategies for DOP. REGISTRATION: This study has been registered in the PROSPERO (CRD42024602637).

Indexed as

Diabetes Mellitus, Type 2OsteoporosisAgedHumansMeta-Analysis as TopicRisk FactorsSystematic Reviews as Topic

Identifiers

PMID40014597
PMCPMC11867315

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.